MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

Meeting: 2024 International Congress

Abstract Number: 46

Keywords: Cognitive dysfunction, Progressive supranuclear palsy(PSP)

Category: Parkinsonism, Atypical: PSP, CBD

Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up and explore the potential contributors for prognosis in the futures.

Background: Nowadays, cognitive impairment has been characterized as one of the most vital clinical symptoms in patients with PSP. High prevalence and severity of cognitive dysfunction were gradually recognized in clinical course.

Method: From Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI) cohort, 97 patients with clinical diagnosed PSP who underwent one-year follow-up, including clinical assessment and neuropsychological tests, were recruited in this study. Patients were divided into normal cognition (PSP-NC), mild cognitive impairment (PSP-MCI) and dementia (PSP-D) according to the diagnostic criteria. MCI converter was defined as those who were PSP-MCI at baseline converted to PSP-D after the follow-up. Paired t test was used for analyzing the difference between baseline and follow-up. The determinants of MCI conversion were calculated by multiple cox regression.

Results: There were 32 patients with PSP were diagnosed as PSP-D (33.0%), 50 patients were diagnosed as PSP-MCI (51.6%), and only 15 patients were diagnosed as PSP-NC (15.5%) at baseline. More than half of patients with PSP-MCI (26/50) converted to Dementia subgroup at the time of follow-up. Extremely rapid disease progression (motor and non-motor symptoms) was found in MCI converters rather than in MCI non-converters. The difference between the two subgroups included higher proportion of Richardson syndrome (RS) subtype (p=0.007), more severely impaired executive functions (p=0.032), language (p=0.035), attention (p=0.029), and non-motor symptoms (p=0.013) in the patients of MCI converter subgroup. Among all the important demographic and clinical variables, the diagnosis of RS subtype was found to be the most significant contributor for the occurrence of the MCI conversion (HR: 3.608, 95% CI: 1.373, 5.997, p=0.009).

Conclusion: The heavy cognition burdens and rapid cognition deteriorations should be well recognized in the PSP. The PSP-RS subtype was the most important predictor to the short-term MCI conversion to dementia in PSP. Our work will be helpful in making a clear prognosis of PSP in the future.

Proportion change of subtypes in PSP

Proportion change of subtypes in PSP

To cite this abstract in AMA style:

XY. Li, G. Tang, FT. Liu, J. Wang. Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/rapid-cognitive-deterioration-and-related-factors-in-progressive-supranuclear-palsy-a-one-year-follow-up-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/rapid-cognitive-deterioration-and-related-factors-in-progressive-supranuclear-palsy-a-one-year-follow-up-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley